Disclosure: This site may earn affiliate commissions when you click provider links. This doesn't affect our recommendations. Learn more
Compounded tirzepatide starts at $169/mo for microdose. Brand Zepbound starts at $299/mo via LillyDirect. We compared 12 providers to find the lowest price.
Tirzepatide produced the largest mean weight loss of any GLP-1 medication studied in head-to-head trials, and it is also the most expensive to source. Compounded tirzepatide starts at $169/month on a microdose program. Brand-name Zepbound starts at $299/month through Eli Lilly's manufacturer-direct program, with practical caveats. Mounjaro, the same active ingredient sold for diabetes, has no manufacturer self-pay program and runs $1,100–$1,900/month at telehealth providers. Compounded tirzepatide is not FDA-approved as a finished product, but for uninsured patients, it remains the primary route to a lower monthly price.
The honest framing: compounded tirzepatide is roughly $50–$100/month more than compounded semaglutide across nearly every provider. That premium is structural, not negotiable. If you're optimizing purely for price, semaglutide is cheaper. If you specifically want tirzepatide, the question becomes which compromise you're willing to make.
Answer 10 questions and we'll match you with the lowest-cost provider that fits your situation.
Take the free quiz →The cheapest verified tirzepatide path in 2026 is Enhance.MD's Microdose Tirzepatide program at $169/month on a 12-month plan ($99 first month). Shed Microdose Tirz is the next-cheapest at $199/month on the same commitment.
Both programs use a roughly 1mg/week dose. This is lower than the 5–15mg/week doses used in the SURMOUNT clinical trials that established Zepbound's efficacy (NEJM, 2022). The weight-loss effect at microdose levels is correspondingly smaller. Microdose programs exist for patients prioritizing tolerability, side-effect minimization, lower cost, or maintenance after reaching goal weight. They're not the right fit if you're targeting the full clinical effect seen in trials.
This distinction matters and rarely gets surfaced clearly on provider websites. A microdose program at $169/month is not equivalent to a full-dose program at $280/month with a discount tacked on. They're different products with different therapeutic targets. Compounded tirzepatide at any dose is not FDA-approved as a finished product.
Prices reflect what providers advertised as of May 2026 and may change. All-inclusive means medication, supplies, shipping, and follow-up visits are covered in one charge. Separate-fee models charge a monthly membership on top of medication costs.
| Provider | Total monthly cost | What's included | Notes |
|---|---|---|---|
| Enhance.MD Microdose | $169/mo (12-mo plan, $99 first month) | All-inclusive | 1mg/wk dose, below SURMOUNT trial range |
| Shed Microdose | $199/mo (12-mo plan) | All-inclusive | Lower microdose injectable |
| TrimRx | Starting at $259/mo (12-mo commitment tier) | All-inclusive | Checkout rate may differ on shorter plans |
| Mochi Health | $278/mo total ($199 medication + $79 membership) | Medication + unlimited physician and dietitian access | Same price every dose; insurance support available |
| Enhance.MD Standard | $99 first month, $280/mo ongoing (12-mo plan) | All-inclusive | Same price every dose |
| Noom Med | $149 first month, $279/mo ongoing | All-inclusive (medication + behavioral coaching) | Full-dose |
| Eden | $249 first month, $329/mo ongoing (3-mo plan) | All-inclusive, same price every dose | |
| Found | $348–$398/mo total ($249 medication + $99–$149 CORE membership) | Medication + clinical coaching + free insurance check | Split billing |
| Henry Meds | $349/mo (3-mo plan) or $297/mo (12-mo paid in full) | All-inclusive | Oral tablets only, no injection format |
| bmiMD | $399/mo standard or $349/mo microdose | All-inclusive | |
| Oak Longevity | $250/mo (3-mo plan) or $285/mo (1-mo plan) starter dose | All-inclusive, no membership | Dose-escalating $50–$75 per step |
| Provider | Total monthly cost | What's included | Notes |
|---|---|---|---|
| LillyDirect | $299/mo (2.5mg), $399/mo (5mg), $449/mo (7.5–15mg) within 45-day refill window | Medication only, no clinical care | $849/mo (12.5mg) or $1,049/mo (15mg) outside refill window |
| WeightWatchers Clinic | $373/mo total ($299 medication + $74 membership) starter dose | Medication + clinical care + WW behavioral program | LillyDirect-equivalent pricing, same 45-day rule |
| Shed | $424/mo total ($299 medication + $125 membership) starter dose | Medication + clinical support | |
| Eden | $299–$699/mo via LillyDirect facilitation | Mirrors LillyDirect pricing | |
| Hers | $448/mo total ($299 medication + $149 membership; $39 first month membership) | Medication + clinical care | |
| Found | $447–$497/mo total ($348 medication + $99–$149 CORE membership) | Medication + clinical coaching + free insurance check | |
| Ro | $299/mo first month, $399–$449/mo ongoing + $149/mo membership | Medication + clinical care | Escalates after first month |
Enhance.MD Microdose at $169/mo is the single cheapest verified path to any tirzepatide product, but the 1mg/wk dose is below the SURMOUNT range and the weight-loss effect is correspondingly smaller. For full-dose compounded tirzepatide, TrimRx at $259/mo on a 12-month commitment is the published floor; verify the checkout rate at intake. Mochi Health at $278/mo total is close behind and adds unlimited physician and dietitian access plus insurance coordination, which can be worth the small premium if you want clinical hand-holding.
On the brand side, LillyDirect at $299/mo starter is the absolute floor, but the 45-day refill rule is a real trap (more below). WeightWatchers Clinic at $373/mo total is the cheapest brand-Zepbound path that includes clinical care.
Across providers, compounded tirzepatide runs $50–$100/month more than compounded semaglutide. There's no clinical or regulatory reason for this. It's a supply problem.
The active pharmaceutical ingredient (API) for tirzepatide is harder to source than semaglutide API. Fewer compounding pharmacies stock it, and the bulk substance costs more to acquire. That cost gets passed through to the patient. Expect the gap to persist as long as supply is constrained, regardless of which provider you choose.
If you're optimizing purely for monthly price and don't have a clinical reason to prefer tirzepatide, compounded semaglutide starts at $149/month and will save you $50–$100/month long-term.
Enhance.MD
$169/mo Microdose or $280/mo Standard (12-mo plan, May 2026)
Microdose program is the cheapest verified tirzepatide path. Standard program holds flat pricing across every dose.
Microdose tirzepatide is a real category with a real use case, but the marketing language tends to blur the boundary between microdose and full-dose. Microdose programs typically use a 1–1.25mg/week injection. SURMOUNT-1, the registrational trial that established Zepbound's efficacy, studied doses of 5mg, 10mg, and 15mg/week.
Microdose makes clinical sense for several patient profiles:
It doesn't make sense if you're targeting the 20%+ body weight reduction seen in SURMOUNT high-dose arms. The dose response for tirzepatide is meaningful: lower dose, smaller effect.
Compounded microdose tirzepatide is not FDA-approved as a finished product, and the specific dose ratios used in microdose programs have not been studied in equivalent clinical trials to the SURMOUNT regimens. Talk to a licensed healthcare provider about whether microdose is appropriate for your situation before signing up.
LillyDirect is the cheapest verified path to brand Zepbound. At starter doses, you pay $299/month (2.5mg), $399/month (5mg), or $449/month (7.5mg, 10mg, 12.5mg, or 15mg). That pricing is competitive with most compounded options and dramatically cheaper than retail Zepbound, which runs roughly $1,350/month at a typical pharmacy.
There's a catch. Eli Lilly's self-pay pricing for the higher Zepbound doses (12.5mg and 15mg) is contingent on refilling within a 45-day window. Miss the window, and 12.5mg jumps to $849/month and 15mg jumps to $1,049/month, per Lilly's self-pay pricing page. The 7.5mg and 10mg doses hold at $449/month regardless of refill timing, but at higher doses, the rule matters.
The practical takeaway: if you're using LillyDirect at 12.5mg or 15mg, set up refill reminders. Pharmacy fulfillment can take several days, so order a few days before you need the refill, not on the day. If you travel often or your prescription schedule is irregular, the savings may not survive a single missed window.
This is where bundled telehealth providers can earn their membership fee. WeightWatchers Clinic offers brand Zepbound at LillyDirect-equivalent pricing for $373/month total ($299 medication + $74 WW membership), with the clinic handling refill logistics. If you can reliably manage the 45-day window yourself, going direct is cheaper. If you can't, paying $74/month for someone else to track it can be worth it.
Shed
$199/mo Microdose, $299/mo brand Zepbound + $125 membership (May 2026)
All-inclusive compounded microdose. Multiple formats including weekly injection, sublingual, and lozenge.
Mounjaro and Zepbound are the same molecule (tirzepatide). The difference is the FDA-approved indication: Mounjaro is approved for type 2 diabetes, Zepbound is approved for obesity and weight management. Eli Lilly priced and marketed them as separate products.
For cash-pay patients, this distinction matters because Lilly offers a manufacturer self-pay program for Zepbound but does not offer one for Mounjaro at weight-loss doses. Every telehealth provider that lists Mounjaro lists it near retail: $1,100–$1,899/month at Hims, Hers, Oak Longevity, Found, and PlushCare.
If you want tirzepatide and you're paying cash, Zepbound is the same molecule at a fraction of the price. Mounjaro through telehealth makes financial sense only if your insurance covers Mounjaro (typically requires a type 2 diabetes diagnosis) and your copay is meaningfully lower than your alternatives.
For patients with insurance that covers GLP-1s, the cheapest path can be brand Zepbound or Mounjaro with prior authorization. Brand Zepbound copays under coverage typically run $25–$100/month.
The catch is that Zepbound is excluded from Medicare Part D and most state Medicaid programs. Coverage is most common through employer-sponsored commercial plans. Mounjaro is more commonly covered but requires a type 2 diabetes diagnosis.
The cheapest insurance-coordinated telehealth paths:
If you have coverage and your plan includes Zepbound on its formulary, expect prior authorization paperwork. PlushCare and Found handle the paperwork on your behalf as part of their service.
The regulatory situation for compounded tirzepatide has tightened significantly. The FDA declared the tirzepatide shortage resolved on October 2, 2024 (FDA drug shortage database). The agency declared the semaglutide shortage resolved in February 2025. Enforcement discretion that previously allowed 503B outsourcing facilities to compound during the shortages ended in spring 2025.
Eli Lilly has pursued aggressive enforcement, filing lawsuits against telehealth companies and compounding pharmacies marketing compounded tirzepatide. Novo Nordisk has taken similar action on the semaglutide side, filing more than 130 lawsuits across 40 states.
The practical result: 503B outsourcing facilities face significant legal restrictions on compounding tirzepatide. 503A pharmacies (which compound for individual patients on a per-prescription basis) operate under different rules and continue to legally compound tirzepatide in most states. Before ordering, confirm which type of pharmacy your provider uses and whether they have received any FDA or legal notices. A reputable provider will be transparent about this.
For deeper context on the regulatory framework and clinical comparison, see our compounded vs brand-name semaglutide guide, which covers most of the same dynamics that apply to tirzepatide.
TrimRx
Starting at $259/mo for compounded tirzepatide (May 2026)
All-inclusive pricing for compounded sema and tirz. Confirm checkout rate at intake; published price reflects a 12-month commitment tier.
Pros
Cons
For most cash-pay patients seeking the lowest monthly price on tirzepatide, the practical recommendations:
A note on Mounjaro: don't choose it for cash-pay weight loss. It's the same molecule as Zepbound at roughly 3x the price. Mounjaro through telehealth makes financial sense only with insurance coverage and a type 2 diabetes diagnosis.
Found
$348/mo medication + $99–$149/mo CORE membership = $447–$497/mo total (May 2026)
Free insurance check, broad medication catalog (compounded tirz, brand Zepbound, plus sema and others), and clinical coaching.
Consult a licensed healthcare provider before starting any GLP-1 medication. Your clinical history, current medications, weight-loss goals, and insurance situation all factor into whether tirzepatide is appropriate for you and which formulation makes sense.